Navigation Links
Topics to be discussed during July International Coral Reef Symposium
Date:6/25/2012

The 12th International Coral Reef Symposium (ICRS 2012), the world's leading coral reef science conference held once every four years, will begin Monday, July 9, in Cairns, Queensland, Australia. Daily media briefings will be held for reporters who are in attendance, and accessibility to this information and to coral experts will be provided through an online media portal to journalists worldwide. In addition to the briefings, journalists will be given daily updates on the groundbreaking presentations in science and management of coral reefs and contact information to pursue additional stories.

The confirmed line-up of daily media briefings, which will include presentations and discussion by scientists and experts in the featured topic areas, follows. The program book and full book of abstracts are available online.

All briefings will be held at the Cairns Convention Centre, Mezzanine level (1st floor), Meeting Room 7 (Press Briefing Room).

Monday, July 9

10:00 a.m. - 11:00 a.m.

The State of Coral Reefs: Leading coral experts present an overview of the state of coral reefs globally and what it will take to manage them sustainably. Briefing includes a discussion of a Consensus Statement on Climate Change and Coral Reefs signed by thousands of scientists worldwide and the expected outcomes from ICRS2012.

Terry Hughes, Director, Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies, James Cook University
Jeremy Jackson, Senior Scientist Emeritus, Smithsonian Institution; Professor of Oceanography Emeritus, Scripps Institution of Oceanography
Stephen R. Palumbi, Jane and Marshall Steel Professor of Marine Science, Department of Biology; Harold A. Miller Director, Hopkins Marine Station, Department of Biology, Stanford University
Robert H. Richmond, President, International Society for Reef Studies; Research Professor, Kewalo Marine Laboratory, University of Hawaii
'/>"/>

Contact: Jackie Marks
media@icrs2012.com
301-495-9570
SeaWeb
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. New heart repair strategies discussed at UH lecture May 15
2. Newly released FDA draft guidelines for biosimilar drugs to be discussed at conference
3. Citizen scientists to document biodiversity with high-resolution imagery during summer solstice
4. Coral reef experts to present latest coral reef science during July symposium
5. Anti-HIV drug use during pregnancy does not affect infant size, birth weight
6. Vitamin D supplements may protect against viral infections during the winter
7. The 1st International Conference on Neurorehabilitation to be held in Toledo, Spain
8. Elsevier launches new journal: International Journal of Disaster Risk Reduction
9. Versatility of zebrafish research highlighted at international conference
10. Digicel Launches Worlds First Biometric Identification System For International Money Transfers
11. OU scientists and international team deciper the genetic code of the tomato
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... allergies and other chronic inflammatory disorders among people of ... their reduced exposure to the microbes that thrive in ... The article, published in the journal Clinical & ... centers who have less access to green spaces may ... caused by immune system dysfunction. , When our immune ...
(Date:4/23/2014)... their mid-thirties and forties, face a devastating prognosis: ... decades. "Mutant" protein clusters, long blamed for the ... primary focus of therapies in development by pharmaceutical ... Gerardo Lederkremer and Dr. Julia Leitman of Tel ... in collaboration with Prof. Ulrich Hartl of the ...
(Date:4/23/2014)... NY. (Apr. 23, 2014) People who have had ... to restore neurological function. However, a study conducted in ... of Cell Transplantation , but is currently freely ... http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1168Chen , has found that when one group of ... (PBSCs) injected directly into the brain and a similar ...
Breaking Biology News(10 mins):Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3On the defensive 2On the defensive 3Autologous stem cell therapy improves motor function in chronic stroke victims 2
... Scientists at the Zucker Hillside Hospital campus of the ... markers that can increase a persons risk for schizophrenia. ... of the National Academy of Sciences, the research team ... be inherited in a recessive manner. A recessive trait ...
... have used ultraviolet light to sculpt three-dimensional microparticles ... and tissue engineering. For example, they could be ... molecules, such as DNA, or to release drugs ... control over the size, shape and texture of ...
... Journal of Lipid Research (Vol. 48, No. 12) ... Disease Increases Progression of Atherosclerosis, Breaking the Vicious Cycle ... Genetic Variants Affect Weight-Associated Cholesterol Metabolism ... alter how the body adjusts cholesterol metabolism in response ...
Cached Biology News:Feinstein researchers develop new genetic method and identify novel genes for schizophrenia 2MIT sculpts 3-D particles with light 2Story ideas from the Journal of Lipid Research 2Story ideas from the Journal of Lipid Research 3
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 AudioNotch is ... new therapy for the treatment of tinnitus. Patients listen ... frequency, and over a period of weeks to months, their ... Therapy in two forms: Notched Music and Notched White Noise. ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... VANCOUVER, March 31 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ... announced it has completed an Amended and Restated ... International Inc. (Baxter). As consideration for the Amended ... receive $25 million. , Angiotech and Baxter initially ...
... AG (VSE: ICLL) today announced that it will host ... and Drug Administration,s (FDA) approval of IXIARO(R), a new ... initial target for use of Intercell,s vaccine - the ... - will be adult travelers and military personnel who ...
... 31 DOR BioPharma, Inc. (OTC Bulletin Board: DORB) ... announced its financial results for 2008. DOR,s revenues for ... in 2007. The increase was due primarily to ... resulting achievement of certain research and development milestones with ...
Cached Biology Technology:Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 2Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 3Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 4Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine 2Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine 3DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 5
Request Info...
"BioTracker 6X Bromophenol Blue Tracking Dye is composed of 60% St DI H2O, 30% Glycerol, 10% 10XTE, 0.25% BPB Dye and 0.85% SDS....
Agarose, low melting/gelling temperature, high MW separation (>1000 bp), 25 g. Suitable for enzymatic modifications. Nuclease-free.Gel point: 24-30 C, EEO (-mr): 300 gm/cm2. Category: Nucleotides &...
Request Info...
Biology Products: